Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment regimen utilizing neratinib for breast cancer

Treatment regimen utilizing neratinib for breast cancer

US Patent 9211291 · Granted Dec 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2016
Anti-tumor activity of CCI-779 in papillary renal cell cancer2014
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2014
Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012